3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Lung Neoplasms
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
Colonic Neoplasms
1
Breast Neoplasms
1
Anus Neoplasms
1
Interventions
Fulvestrant
26
Letrozole
25
Specimen Handling
19
ribociclib
18
Capecitabine
16
pembrolizumab
15
palbociclib
13
Trastuzumab
13
Paclitaxel
13
abemaciclib
12
Tamoxifen
12
Anastrozole
12
exemestane
11
Magnetic Resonance Spectroscopy
11
trastuzumab deruxtecan
10
Carboplatin
10
Biopsy
9
pertuzumab
8
Goserelin
8
inavolisib
6
Standard of Care
6
Cyclophosphamide
6
olaparib
5
giredestrant
5
elacestrant
5
Taxes
5
Radiotherapy
5
Radiation
5
130-nm albumin-bound paclitaxel
5
pyrotinib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Neoplasms
×
Radionuclide Imaging
×
30 days
×
Clear all
NCT06904365
2026-05-18
OvAR-Y
Washington University School of Medicine
Active not recruiting
10 enrolled